Peter Verdult

Stock Analyst at Citigroup

(0.10)
# 4,412
Out of 5,044 analysts
5
Total ratings
20%
Success rate
-23.65%
Average return

Stocks Rated by Peter Verdult

Eli Lilly and Company
Jan 28, 2025
Maintains: Buy
Price Target: $1,250$1,190
Current: $819.20
Upside: +45.26%
Evotec SE
Jun 8, 2023
Upgrades: Buy
Price Target: n/a
Current: $4.09
Upside: -
Galapagos NV
Jan 27, 2022
Upgrades: Buy
Price Target: n/a
Current: $31.02
Upside: -